Floatz logo

DESFERRIOXAMINE B

Chronic Cutaneous Ulcer

TauTona GroupSmall moleculePhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Chronic Cutaneous Ulcer cohort.

Asset / SponsorPhaseRating
NEPENTHE
Institut Curie
Phase 3B
HYALURONATE
Nakhia Impex LLC
N/AD
ha35
Nakhia Impex LLC
N/AD
Arginine Butyrate
Susan P. Perrine
Phase 2NR

Same molecule, other indications

DESFERRIOXAMINE B is also rated in:

beta-thalassemia majorDormant
BBB
Indicative ·
75 / 100
View asset →
iron metabolism diseaseDormant
BBB
Indicative ·
73 / 100
View asset →
hemosiderosisDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →